Capital Expenditures - Cutia Therapeutics (HKEX:2487) - Alpha Spread
C

Cutia Therapeutics
HKEX:2487

Watchlist Manager
Cutia Therapeutics
HKEX:2487
Watchlist
Price: 14.06 HKD -0.28%
Market Cap: 4.3B HKD
Have any thoughts about
Cutia Therapeutics?
Write Note

Cutia Therapeutics
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cutia Therapeutics
Capital Expenditures Peer Comparison

Comparables:
6160
1801
9926
603392
300122

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
C
Cutia Therapeutics
HKEX:2487
Capital Expenditures
-ÂĄ55.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Capital Expenditures
-ÂĄ4.1B
CAGR 3-Years
-61%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Capital Expenditures
-ÂĄ1.4B
CAGR 3-Years
-38%
CAGR 5-Years
-35%
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Capital Expenditures
-ÂĄ879.5m
CAGR 3-Years
-25%
CAGR 5-Years
-64%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Capital Expenditures
-ÂĄ1.2B
CAGR 3-Years
-44%
CAGR 5-Years
-36%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Capital Expenditures
-ÂĄ1B
CAGR 3-Years
14%
CAGR 5-Years
-14%
CAGR 10-Years
-16%

See Also

What is Cutia Therapeutics's Capital Expenditures?
Capital Expenditures
-55.9m CNY

Based on the financial report for Dec 31, 2023, Cutia Therapeutics's Capital Expenditures amounts to -55.9m CNY.

What is Cutia Therapeutics's Capital Expenditures growth rate?
Capital Expenditures CAGR 1Y
59%

Over the last year, the Capital Expenditures growth was 59%.

Back to Top